Gruss Capital Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
Other funds holding GCVRZ
SCM
EM
MCM
TGHSA
BCM
HCM
WA
FCM
NGA
MFP
Gruss Capital Management's GCVRZ Position: Q4 2018 in Review
Gruss Capital Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2018, closing a stake of 4,586,200 shares — an estimated $2.43M sold.
Gruss Capital Management first reported a position in GCVRZ in Q2 2013 and held it in 22 quarters. The position peaked at $5.24M in Q3 2013. 103 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2018.
- Gruss Capital Management reported no remaining Sanofi Contingent Value Rights position as of Q4 2018 after selling out during the quarter.
- Gruss Capital Management sold 4,586,200 Sanofi Contingent Value Rights shares in Q4 2018, an estimated $2.43M.
- Gruss Capital Management first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 22 quarters.
- Gruss Capital Management's Sanofi Contingent Value Rights position peaked at $5.24M in Q3 2013.
- 103 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2018.
Based on Gruss Capital Management's 13F filing for Q4 2018.